DEFA14A: GoodRx Appoints Simon Patterson to Board of Directors Following Adam Karol's Resignation

GoodRx Holdings, Inc. has appointed Simon Patterson to its Board of Directors, effective immediately, following the resignation of Adam Karol in March 2024.

Summary

• GoodRx Holdings, Inc. announced the appointment of Simon Patterson to its Board of Directors, effective May 29, 2024.
• Mr. Patterson fills the vacancy created by the resignation of Adam Karol in March 2024.
• He will serve as a Class II director, with his term expiring at the 2025 Annual Meeting of Stockholders.
• Mr. Patterson has also been appointed to the Board's Nominating and Corporate Governance Committee.
• The Board has determined that Mr. Patterson qualifies as an independent director under Nasdaq rules.
• Mr. Patterson will not receive compensation for his service on the Board.
• The appointment does not change the proposals to be voted on at the Annual Meeting or the Board's recommendations.
• Stockholders who have already voted do not need to take additional action unless they wish to change their vote.

Sentiment

Score: 7

Explanation: The announcement is a routine corporate governance update, indicating stability and adherence to corporate procedures. The appointment of an experienced director from a reputable firm is generally viewed positively.

Positives

• The appointment of Simon Patterson brings significant financial and management expertise to the GoodRx Board.
• Mr. Patterson's experience in technology and technology-enabled companies is expected to benefit GoodRx.
• His independence under Nasdaq rules ensures objective oversight.
• The Silver Lake Stockholders retain the right to designate one additional director, providing them with continued influence.

Future Outlook

The document does not contain specific forward-looking statements beyond the term expiration of the newly appointed director at the 2025 Annual Meeting.

Industry Context

The appointment of a director with a strong technology investment background aligns with the ongoing trend of healthcare companies seeking expertise in digital transformation and technology-driven solutions.

Management Changes

Related Party Transactions

• The Company is party to a Stockholders Agreement with SLP Geology Aggregator, L.P. (affiliated with Silver Lake), which grants certain board designation rights.

Stakeholder Impact

• Shareholders are informed of the change in the Board composition.
• The appointment of an experienced director may positively influence investor confidence.

Next Steps

• Simon Patterson will serve on the Board and the Nominating and Corporate Governance Committee.
• Stockholders are encouraged to have their shares represented and voted at the Annual Meeting.

Key Dates

Keywords

Board of Directors, Simon Patterson, Adam Karol, GoodRx, Appointment, Resignation, Nominating and Corporate Governance Committee, Silver Lake, Director, Governance